• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6基因-634C/G多态性与骨质疏松症关联的Meta分析

Meta-analysis of association between IL-6 -634C/G polymorphism and osteoporosis.

作者信息

Yan L, Hu R, Tu S, Cheng W J, Zheng Q, Wang J W, Kan W S, Ren Y J

机构信息

Department of Reparative and Reconstructive Surgery of Orthopedics, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Genet Mol Res. 2015 Dec 29;14(4):19225-32. doi: 10.4238/2015.December.29.32.

DOI:10.4238/2015.December.29.32
PMID:26782575
Abstract

Osteoporosis is a common disease in the aging population and studies have shown that interleukin-6 (IL-6) is potentially implicated in its pathogenesis. This study was designed to assess the association between the IL-6 gene -634C/G polymorphism and osteoporosis. PubMed, Embase, China National Knowledge Infrastructure, and Wanfang databases were searched for eligible studies published up to and including December 2014 in English or Chinese. Meta-analysis was conducted by the RevMan5.2 software. Weighted mean difference and 95% confidence interval (95%CI) were calculated by a fixed-effect or random-effect model. Bone mineral density (BMD) was regarded as the assessment index. As a result, a total of four articles with 3068 subjects were included. Differences in BMD between the CC and GG genotypes were 0.03 g/cm(2) (95%CI = 0.01 to 0.05) at total body, 0.01 g/cm(2) (95%CI = 0.00 to 0.03) at femoral neck, and 0.03 g/cm(2) (95%CI = 0.00 to 0.06) at the lumbar spine (P < 0.05). For the CG versus GG genotypes, the differences in BMD were 0.03 g/cm(2) (95%CI = 0.02 to 0.05) at total body and 0.02 g/cm(2) (95%CI = 0.00 to 0.03 at the femoral neck (P < 0.05). For the CC versus CG genotypes, the differences in BMD were not significant (P > 0.05). In conclusion, the GG genotype of the -634C/G polymorphism in IL-6 appears to play a role in reducing BMD, which affects normal bone metabolism and leads to osteoporosis.

摘要

骨质疏松症是老年人群中的常见疾病,研究表明白细胞介素-6(IL-6)可能与其发病机制有关。本研究旨在评估IL-6基因-634C/G多态性与骨质疏松症之间的关联。检索了PubMed、Embase、中国知网和万方数据库,查找截至2014年12月(含)发表的英文或中文合格研究。使用RevMan5.2软件进行荟萃分析。采用固定效应或随机效应模型计算加权平均差和95%置信区间(95%CI)。将骨密度(BMD)作为评估指标。结果,共纳入4篇文章,涉及3068名受试者。CC和GG基因型在全身的BMD差异为0.03g/cm²(95%CI = 0.01至0.05),在股骨颈为0.01g/cm²(95%CI = 0.00至0.03),在腰椎为0.03g/cm²(95%CI = 0.00至0.06)(P < 0.05)。对于CG与GG基因型,全身的BMD差异为0.03g/cm²(95%CI = 0.02至0.05),在股骨颈为0.02g/cm²(95%CI = 0.00至0.03)(P < 0.05)。对于CC与CG基因型,BMD差异无统计学意义(P > 0.05)。总之,IL-6基因-634C/G多态性的GG基因型似乎在降低BMD方面起作用,这影响正常骨代谢并导致骨质疏松症。

相似文献

1
Meta-analysis of association between IL-6 -634C/G polymorphism and osteoporosis.白细胞介素-6基因-634C/G多态性与骨质疏松症关联的Meta分析
Genet Mol Res. 2015 Dec 29;14(4):19225-32. doi: 10.4238/2015.December.29.32.
2
Association between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysis.白细胞介素-6基因多态性与骨密度的关联:一项荟萃分析。
Genet Test Mol Biomarkers. 2013 Dec;17(12):898-909. doi: 10.1089/gtmb.2013.0223. Epub 2013 Sep 21.
3
Association of IL-6 G-174C polymorphism with bone mineral density.白细胞介素 6 G-174C 多态性与骨密度的关系。
J Bone Miner Metab. 2014 Mar;32(2):167-73. doi: 10.1007/s00774-013-0477-2. Epub 2013 Jun 13.
4
Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis.亚甲基四氢叶酸还原酶 C667T 多态性与骨密度和骨折风险的关系:一项更新的荟萃分析。
Osteoporos Int. 2012 Nov;23(11):2625-34. doi: 10.1007/s00198-011-1885-6. Epub 2011 Dec 21.
5
Interactions of interleukin-6 gene polymorphisms with calcium intake and physical activity on bone mass in pre-menarche Chinese girls.白细胞介素-6基因多态性与钙摄入量及身体活动对初潮前中国女孩骨量的相互作用。
Osteoporos Int. 2008 Nov;19(11):1629-37. doi: 10.1007/s00198-008-0613-3. Epub 2008 Apr 17.
6
The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women.雌激素受体1基因影响斯洛伐克绝经后女性的骨密度和骨质疏松症治疗效果。
BMC Med Genet. 2018 Sep 21;19(1):174. doi: 10.1186/s12881-018-0684-8.
7
The IL6 gene polymorphism -634C>G and IL17F gene polymorphism 7488T>C influence bone mineral density in young and elderly Japanese women.IL6 基因多态性-634C>G 和 IL17F 基因多态性 7488T>C 影响年轻和老年日本女性的骨密度。
Gene. 2012 Aug 1;504(1):75-83. doi: 10.1016/j.gene.2012.04.054. Epub 2012 May 2.
8
Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study.白细胞介素-6基因多态性与健康白人男性青春期及青春期后骨密度的关系:一项横断面和纵向研究
J Bone Miner Res. 2000 Oct;15(10):1944-9. doi: 10.1359/jbmr.2000.15.10.1944.
9
Association of estrogen receptor alpha gene polymorphisms with bone mineral density in Chinese women: a meta-analysis.雌激素受体α基因多态性与中国女性骨密度的关联:一项荟萃分析。
Osteoporos Int. 2007 Mar;18(3):295-305. doi: 10.1007/s00198-006-0239-2. Epub 2006 Nov 7.
10
Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.转化生长因子β1基因多态性与骨质疏松症
Bone. 2003 Mar;32(3):297-310. doi: 10.1016/s8756-3282(02)00971-7.

引用本文的文献

1
Immunologic Aspects in Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良的免疫学方面。
Biomolecules. 2024 Mar 16;14(3):357. doi: 10.3390/biom14030357.
2
Network pharmacology-based pharmacological mechanism prediction of Lycii Fructus against postmenopausal osteoporosis.基于网络药理学的枸杞子防治绝经后骨质疏松症的药理机制预测。
Medicine (Baltimore). 2023 Dec 1;102(48):e36292. doi: 10.1097/MD.0000000000036292.
3
Association of TNF-α, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease.
TNF-α、IGF-1 和 IGFBP-1 水平与非酒精性脂肪肝小鼠骨质疏松严重程度的相关性。
J Orthop Surg Res. 2023 Dec 1;18(1):915. doi: 10.1186/s13018-023-04385-1.
4
14-3-3η protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis.14-3-3η蛋白与类风湿关节炎患者的疾病活动度及骨质疏松相关。
Reumatologia. 2022;60(6):384-391. doi: 10.5114/reum.2022.123669. Epub 2022 Dec 30.
5
Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis.基于网络药理学的策略探讨六味地黄丸治疗绝经后骨质疏松症的药理机制。
Medicine (Baltimore). 2022 Nov 25;101(47):e31387. doi: 10.1097/MD.0000000000031387.
6
Osteopontin, a bridge links osteoarthritis and osteoporosis.骨桥蛋白,连接骨关节炎与骨质疏松的桥梁。
Front Endocrinol (Lausanne). 2022 Oct 28;13:1012508. doi: 10.3389/fendo.2022.1012508. eCollection 2022.
7
Osteomuscular symptoms on motorcycles in the city of Rio Branco, Acre, Brazil, West Amazon.巴西亚马孙西部阿克里州里奥布朗库市摩托车致肌骨症状。
Medicine (Baltimore). 2021 Apr 23;100(16):e25549. doi: 10.1097/MD.0000000000025549.
8
New Therapeutic Approaches and Biomarkers for Increased Healthspan.延长健康寿命的新治疗方法和生物标志物。
Adv Exp Med Biol. 2021;1286:1-13. doi: 10.1007/978-3-030-55035-6_1.
9
No Interaction Effect between Interleukin-6 Polymorphisms and Acid Ash Diet with Bone Resorption Marker in Postmenopausal Women.绝经后妇女中白细胞介素-6 多态性与酸性灰饮食对骨吸收标志物无交互作用。
Int J Environ Res Public Health. 2021 Jan 19;18(2):827. doi: 10.3390/ijerph18020827.
10
The association among 14-3-3η protein, inflammation, bone remodeling and osteoporosis in patients with rheumatoid arthritis.类风湿关节炎患者中14-3-3η蛋白、炎症、骨重塑与骨质疏松之间的关联。
Pak J Med Sci. 2020 Jul-Aug;36(5):872-876. doi: 10.12669/pjms.36.5.2403.